- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Avalon GloboCare Appoints Dr. Bo Chen as Vice President of Mergers & Acquisitions
Avalon GloboCare (OTCQB:AVCO), a leading global developer of cell-based technologies announced the Company has appointed Dr. Bo Chen as Vice President, Business Development to lead mergers & acquisitions activity. Dr. Chen will focus on executing Avalon’s acquisition strategy by helping identify companies with a strategic fit within the cell therapeutics, cell diagnostics and rehabilitation sectors. As …
Avalon GloboCare (OTCQB:AVCO), a leading global developer of cell-based technologies announced the Company has appointed Dr. Bo Chen as Vice President, Business Development to lead mergers & acquisitions activity. Dr. Chen will focus on executing Avalon’s acquisition strategy by helping identify companies with a strategic fit within the cell therapeutics, cell diagnostics and rehabilitation sectors.
As quoted in the press release:
Dr. Bo Chen was one of the original founders of the Ludaopei Hospital Group in China, and has served as the global business development director for the past 5 years. The Ludaopei Hospital Group is one of the fastest growing private medical companies in China presently, consisting of multiple hospitals and research centers specialized in leukemia and cell therapeutics.
Click here to read the full press release.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.